(19)
(11) EP 1 244 686 A1

(12)

(43) Date of publication:
02.10.2002 Bulletin 2002/40

(21) Application number: 00983862.4

(22) Date of filing: 01.12.2000
(51) International Patent Classification (IPC)7C07H 21/04, C12N 1/21, C12N 15/00, C12P 21/00, C07K 14/495, C07K 16/22, A61K 38/18, A61K 48/00, C12Q 1/68, G01N 33/53
(86) International application number:
PCT/US0032/745
(87) International publication number:
WO 0104/0251 (07.06.2001 Gazette 2001/23)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 02.12.1999 US 168387 P

(71) Applicant: Human Genome Sciences, Inc.
Rockville, MD 20850 (US)

(72) Inventor:
  • WEI, Ying-Fei
    Berkeley, CA 94705 (US)

(74) Representative: VOSSIUS & PARTNER 
Siebertstrasse 4
81675 München
81675 München (DE)

   


(54) TRANSFORMING GROWTH FACTOR ALPHA HIII